EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The Urea–Creatinine Ratio as Marker of Catabolism Is Affected by Continuous Renal Replacement Therapy

Andreas Markl-Le Levé iD, Petra Hillinger, Simon Woyke, Marco Ronzani, Stefan Schmid iD, Janett Kreutziger, Christopher Rugg iD

Diagnostics · 01.06.2025 · 15 (11) · 1408

DOI: 10.3390/diagnostics15111408 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diagnostics, online erschienen am 01.06.2025. Verfasst von Andreas Markl-Le Levé und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anaesthesiology and Critical Care Medicine, Medical University of Innsbruck, Anichstrasse 35, 6020 Innsbruck, Austria. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

An elevated urea–creatinine ratio (UCR) is used as a surrogate for catabolism and elevated protein metabolism in critically ill patients. This study investigated the effect of continuous renal replacement therapy (CRRT) on UCR.

Methods

In this retrospective single-centre study, ICU patients from 2011 to 2022 with an ICU stay >2 days before CRRT and a CRRT duration of ≥4 days were included. Patients were grouped by UCR at CRRT initiation into high (UCR ≥ 75 mg/dL:mg/dL) and low groups and compared to matched controls not requiring CRRT. Propensity score matching considered age, sex, bodyweight, SAPS3, SOFA score, and UCR values on baseline and pre-baseline days.

Results

In the high UCR group, UCR significantly decreased after CRRT initiation, reaching a significant difference from controls on day 2 (85.0 [IQR: 69.5–96.4] vs. 94.4 [IQR: 83.0–115.2]; p = 0.036) and falling below the threshold of 75 by day 3. In the low group, UCR increased post-CRRT initiation, but was less pronounced than in controls, with significant differences on day 1 (44.0 [IQR: 34.2–59.8] vs. 40.6 [IQR: 32.1–52.5]; p = 0.024).

Conclusions

CRRT significantly affects UCR in critically ill patients, showing a marked decrease when compared to matched controls.

Schlagwörter

Stichwörter der Autor:innen

acute kidney injurycatabolismcontinuous renal replacement therapycreatinineureaurea–creatinine ratio

Autor:innen und Institutionen

  • Department of Anaesthesiology and Critical Care Medicine, Medical University of Innsbruck, Anichstrasse 35, 6020 Innsbruck, Austria.

ORCID-Profile: Andreas Markl-Le Levé, Stefan Schmid, Christopher Rugg

Zitieren

APA

Markl-Le Levé, A., Hillinger, P., Woyke, S., Ronzani, M., Schmid, S., Kreutziger, J., & Rugg, C. (2025). The Urea–Creatinine Ratio as Marker of Catabolism Is Affected by Continuous Renal Replacement Therapy. Diagnostics, 15(11), 1408. https://doi.org/10.3390/diagnostics15111408

Vancouver

Markl-Le Levé A, Hillinger P, Woyke S, Ronzani M, Schmid S, Kreutziger J, et al. The Urea–Creatinine Ratio as Marker of Catabolism Is Affected by Continuous Renal Replacement Therapy. Diagnostics. 2025;15(11):1408. doi:10.3390/diagnostics15111408

BibTeX
@article{MarklLeLev2025,
  author = {Markl-Le Levé, Andreas and Hillinger, Petra and Woyke, Simon and Ronzani, Marco and Schmid, Stefan and Kreutziger, Janett and Rugg, Christopher},
  title = {The Urea–Creatinine Ratio as Marker of Catabolism Is Affected by Continuous Renal Replacement Therapy},
  journal = {Diagnostics},
  year = {2025},
  volume = {15},
  number = {11},
  pages = {1408},
  doi = {10.3390/diagnostics15111408}
}
Kostenlos starten →